Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795741 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms
A NA study, sponsored by Englewood Hospital and Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02795741: Completed NA study, sponsored by Englewood Hospital and Medical Center.
NCT02795741 is a NA study that has completed, run by Englewood Hospital and Medical Center. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02795741, a NA study, has completed, sponsored by Englewood Hospital and Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The Cooling Bolero is a a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat. The vest is manufactured by Nanohealth. It intended to provide moderate cooling (\~15C/59F) through indirect contact with the skin. The material in the device is safe, non-toxic, and eco-friendly. Recent anecdotal studies of women with common peri-menopausal and menopausal symptoms (hot flashes, night sweats, flushing/sweating of face and neck, and intermittent sleep disturbances) have shown a reduction in both the frequency and intensity of those symptoms after using the Cooling Bolero. Specific (moderate) temperature cooling of the neck and upper torso appears to target and mitigate these common menopausal symptoms. This pilot study attempts to collect additional data on the effects of the Cooling Bolero.
Primary Outcome
Diaries will be used to capture data pre-intervention, during the intervention, and post-intervention
Interventions
- DEVICE Cooling Bolero
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02795741 record still lists
NCT02795741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Cooling Bolero is the first listed.
NCT02795741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02795741 about?
NCT02795741 is a clinical study titled "Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms". The Cooling Bolero is a a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat. The vest is manufactured by Nanohealth. It intended to provide moderate cooling (\~15C/59F) through indirect contact with the skin. The material in the device is safe, non...
What is the current status of trial NCT02795741?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-07. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02795741?
The interventions under investigation include: Cooling Bolero (DEVICE).
Who is sponsoring clinical trial NCT02795741?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02795741's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia